Skip to content

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

Assessment of Retinal Photoreceptor Outer Segment Length With Optical Coherence Tomography Before and After Light Stimulation - a Pilot Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03921931
Enrollment
35
Registered
2019-04-19
Start date
2018-11-26
Completion date
2026-05-31
Last updated
2025-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Degeneration, Dry, Primary Open-angle Glaucoma

Keywords

light stimulation, retinal photoreceptors, light adaptation, functional optical coherence tomography, optophysiology, intrinsic optical signals

Brief summary

It has been shown that reactions of human retinal photoreceptors to a light stimulus can be measured with custom-made, research prototype optical coherence tomography (OCT) systems. This can be used as a biomarker for the function of the photoreceptors. Due to the high technical demands on the system, however, the technique is currently not available for clinical purposes. In this pilot study a protocol to measure changes in retinal photoreceptor layer thickness before and after light stimulation shall be developed based on a commercial OCT system and newly developed algorithms. Other variables, such as circadian processes shall be investigated as well. After measurements in healthy volunteers, the protocol is planned to be applied in patients with primary open angle glaucoma (POAG) and age-related macular degeneration (AMD) to test for feasibility of the method in these patient groups.

Interventions

OTHERWhite light stimulation

Stimulation of the retina with white light

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* men and women aged over 18 years * signed informed consent form * ametropia below 3 diopters * ability and willingness to follow instructions for healthy volunteers: * normal ophthalmologic findings for primary open angle glaucoma patients (POAG): * diagnosed POAG * MD \<= 10 dB for age-related macular degeneration (AMD): * diagnosed dry AMD * diagnosed stage II or stage III AMD

Exclusion criteria

* Presence of any abnormalities preventing reliable measurements * Ocular inflammation and ocular disease interfering with the study aims * Use of photosensitizing medication (phototoxic drugs, photoallergic drugs) in the 3 months preceding the study * Presence of any condition with the possibility of causing photosensitivity, including systemic lupus erythematosus SLE, Porphyria, Vitiligo, Xeroderma Pigmentosum and Albinism * Presence of any form of epilepsy * Ocular surgery in the 3 months preceding the study * Pregnancy, planned pregnancy or lactating * Any medical or surgical history, disorder or disease such as acute or chronic severe organic disease

Design outcomes

Primary

MeasureTime frameDescription
Light stimulation1 dayOptical path length changes between inner segment outer segment junction and retinal pigment epithelium (RPE) will be measured with OCT in 15 healthy volunteers, 10 POAG patients and 10 AMD patients before and after light stimulation

Secondary

MeasureTime frameDescription
Light stimulation of contralateral eye1 dayOptical path length changes between inner segment outer segment junction and retinal pigment epithelium (RPE) will be measured with OCT in 15 healthy volunteers, 10 POAG patients and 10 AMD patients before and after light stimulation in the contralateral eye
Difference in photoreceptor layer thickness over the course of 8 hours8 hoursInfluence of circadian rhythm on the length of retinal photoreceptor outer segments
En face maps1 daytest an algorithm for production of en face maps of retinal photoreceptor outer segment length

Countries

Austria

Contacts

Primary ContactDoreen Schmidl, MD,PhD
doreen.schmidl@meduniwien.ac.at0043140400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026